Total Funding
28
45
Total FundingVenture - Series Unknown raised
Growth Score 28 in past quarter
-15 pts
Heat Score 45 in past quarter
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
120458
Origin is a privately-held, clinical-stage biotechnology company developing a medical technology to deliver therapeutic molecules.
- Dibya Ranjan Giri: Intern
- Michael D. Preston: Founder ,Chairman & CEO
About the Company
Origin is a privately-held, clinical-stage biotechnology company developing a medical technology to deliver therapeutic molecules. It is mainly for the targeted delivery of nitric oxide, used to treat pain and inflammation, wounds, ulcers, and infections of the skin and soft tissues, enhancing and saving lives through applications in medicine and
agribusiness.